| 1.7213 0.071 (4.32%) | 03-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.34  |
1-year : | 2.8 |
| Resists | First : | 2 |
Second : | 2.4 |
| Pivot price | 1.61 |
|||
| Supports | First : | 1.37 | Second : | 1.13 |
| MAs | MA(5) : | 1.62 |
MA(20) : | 1.61 |
| MA(100) : | 2.59 |
MA(250) : | 1.71 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 36.5 |
D(3) : | 29.8 |
| RSI | RSI(14): 45.6 |
|||
| 52-week | High : | 5.07 | Low : | 0.72 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RDGT ] has closed below upper band by 21.9%. Bollinger Bands are 71.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.72 - 1.73 | 1.73 - 1.74 |
| Low: | 1.57 - 1.58 | 1.58 - 1.59 |
| Close: | 1.71 - 1.72 | 1.72 - 1.73 |
Ridgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.
Wed, 12 Nov 2025
S&P 500 rises, Dow Jones breaches records but NASDAQ falls as Wall Street ends day on a high: Leifras jump - The Economic Times
Tue, 11 Nov 2025
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com UK
Tue, 11 Nov 2025
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com
Mon, 10 Nov 2025
Ridgetech completes $2.8 million private placement of shares and warrants - Investing.com
Mon, 28 Jul 2025
RDGT Stock Price, News & Analysis - Stock Titan
Tue, 24 Jun 2025
Is Walgreens Stock Underperforming the Nasdaq? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 18 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 12.3 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 13 (K) |
| Shares Short P.Month | 37 (K) |
| EPS | -0.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.05 |
| Profit Margin | 8.5 % |
| Operating Margin | -0.9 % |
| Return on Assets (ttm) | -0.9 % |
| Return on Equity (ttm) | -6.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.2 |
| Sales Per Share | 6.55 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | -19 (M) |
| PE Ratio | -6.63 |
| PEG Ratio | 0 |
| Price to Book value | 0.34 |
| Price to Sales | 0.26 |
| Price to Cash Flow | 25.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|